CTOs on the Move


 
LENSAR, Inc. is a global leader in next-generation femtosecond laser technology for refractive cataract surgery. The LENSAR Laser System offers cataract surgeons precision, accuracy, and efficiency while optimizing overall visual outcomes. LENSAR`s proprietary Augmented Reality technology -- reconstructed 3-D imaging, measurement, and guidance system -- offers quick and easy patient docking and provides high-resolution ocular images in a single scan. This technology facilitates enhanced procedure outcomes by allowing the physician to develop individualized treatment plans including precise laser delivery, and efficient lens fragmentation that can reduce, and potentially eliminate phaco energy. The LENSAR Laser System also offers the industry`s smallest ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.lensar.com
  • 2800 Discovery Drive
    Orlando, FL USA 32826
  • Phone: 888.536.7271

Executives

Name Title Contact Details

Similar Companies

Applied Nutrition

Applied Nutrition is a Culver City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

medical supply net

medical supply net is a San Dimas, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lifespan of Battle Creek

Lifespan of Battle Creek is a Battle Creek, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NextStep Arthropedix

NextStep Arthropedix is a medical device manufacturer focused on designing, developing, manufacturing, and distributing joint replacement implant and instrument products for hip and knee arthroplasty. This company is at the forefront of designing and manufacturing innovative implants characterized by the advantages of 3D printing technology.

LuxCath

LuxCath is the leader in using fluorescence and optics to directly view lesions during cardiac ablation procedures. The company`s breakthrough technology offers the potential for dramatic evolution in the way ablation procedures are performed by assessing tissue contact and enabling direct lesion progression monitoring. LuxCath`s patented solution aims to ensure the quality of catheter lesions at the moment they are made. LuxCath enables constant optical tissue contact assessment and provides valuable lesion formation and progression information during each ablation.